-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 28, the National Health and Health Commission issued a message to guide medical institutions to scientifically set management indicators for the clinical application of anti-tumor drugs and improve the level of clinically reasonable application of anti-tumor drugs.
The full text is as follows:
Notice of the General Office of the National Health Commission on Issuing the Management Indicators for the Rational Application of Anti-tumor Drugs (2021 Edition)
Notice of the General Office of the National Health Commission on Issuing the Management Indicators for the Rational Application of Anti-tumor Drugs (2021 Edition)National Health Office Medical Letter (2021) No.
National Health Office Medical Letter (2021) No.
In order to implement the "Administrative Measures for the Clinical Application of Anti-tumor Drugs (Trial)" (Guowei Medical Letter [2020] No.
Attachment: Management indicators for the rational clinical application of anti-tumor drugs (2021 version)
General Office of the National Health Commission
June 17, 2021